$6.80
-0.04-0.58%
In chiusura: -
$6.70
-0.1-1.47%
After hour: 9:28 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Champions Oncology segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
dic 10
Stima EPS
$0.010
Stima dei ricavi trimestrali
$14.04M
Ricavi annuali
(a partire da lug 31)
(a partire da lug 31)
$56.88M
Analizza lo storico degli utili di Champions Oncology utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CSBR | Champions Oncology | $0.05 | $0.01 | — | — | $13.49M | $14.04M | — | — | 12/10/2025 | |
CSBR | Champions Oncology | $0.11 | -$0.01 | $0.02 | 300.00% | $14.06M | $13.51M | $13.99M | 3.57% | 09/15/2025 | |
CSBR | Champions Oncology | $0.01 | -$0.20 | -$0.07 | 65.00% | $14.00M | $12.01M | $12.36M | 2.85% | 07/23/2025 | |
CSBR | Champions Oncology | -$0.16 | $0.30 | $0.36 | 20.00% | $12.02M | — | $17.04M | — | 03/11/2025 | |
CSBR | Champions Oncology | -$0.15 | $0.01 | $0.05 | 400.00% | $11.57M | $13.05M | $13.49M | 3.36% | 12/11/2024 | |
CSBR | Champions Oncology | -$0.16 | -$0.03 | $0.11 | 466.67% | $12.56M | $13.23M | $14.06M | 6.28% | 09/11/2024 | |
CSBR | Champions Oncology | -$0.17 | -$0.16 | $0.01 | 106.25% | $13.07M | $12.69M | $14.00M | 10.33% | 07/18/2024 | |
CSBR | Champions Oncology | -$0.16 | -$0.15 | -$0.16 | -6.67% | $12.77M | $13.48M | $12.02M | -10.84% | 03/12/2024 | |
CSBR | Champions Oncology | $0.01 | -$0.17 | -$0.15 | 11.76% | $14.28M | $12.84M | $11.57M | -9.87% | 12/12/2023 | |
CSBR | Champions Oncology | $0.00 | -$0.10 | -$0.16 | -60.00% | $13.74M | $13.06M | $12.56M | -3.82% | 09/13/2023 | |
CSBR | Champions Oncology | -$0.02 | -$0.12 | -$0.17 | -41.67% | $12.88M | $12.86M | $13.07M | 1.64% | 07/24/2023 | |
CSBR | Champions Oncology | $0.07 | -$0.03 | -$0.16 | -433.33% | $13.19M | $13.13M | $12.77M | -2.72% | 03/15/2023 | |
CSBR | Champions Oncology | $0.03 | -$0.01 | $0.01 | 200.00% | $11.79M | $13.79M | $14.28M | 3.56% | 12/13/2022 | |
CSBR | Champions Oncology | $0.01 | $0.01 | $0.00 | -100.00% | $11.25M | $13.19M | $13.74M | 4.21% | 09/08/2022 | |
CSBR | Champions Oncology | -$0.04 | $0.02 | -$0.02 | -200.00% | $10.56M | $12.72M | $12.88M | 1.23% | 07/21/2022 | |
CSBR | Champions Oncology | $0.05 | $0.02 | $0.07 | 250.00% | $10.81M | $12.47M | $13.19M | 5.80% | 03/15/2022 | |
CSBR | Champions Oncology | $0.00 | $0.00 | $0.02 | 100.00% | $10.12M | $11.55M | $11.79M | 2.04% | 12/13/2021 | |
CSBR | Champions Oncology | $0.01 | $0.01 | $0.01 | 0.00% | $9.55M | $10.97M | $11.25M | 2.58% | 09/13/2021 | |
CSBR | Champions Oncology | -$0.14 | $0.00 | -$0.04 | -100.00% | $8.75M | $10.03M | $10.56M | 5.33% | 07/22/2021 | |
CSBR | Champions Oncology | $0.03 | $0.01 | $0.05 | 400.00% | $9.01M | $10.14M | $10.81M | 6.63% | 03/11/2021 | |
CSBR | Champions Oncology | $0.03 | — | $0.00 | — | $7.63M | $9.38M | $10.12M | 7.86% | 12/14/2020 |
Champions Oncology (CSBR) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-09-15 | $0.02 | $-0.01 | 300.0 % |
| Q4 | 2025-07-23 | $-0.07 | $-0.20 | 65.0 % |
| Q3 | 2025-03-11 | $0.36 | $0.30 | 20.0 % |
| Q2 | 2024-12-11 | $0.05 | $0.01 | 400.0 % |
Champions Oncology (CSBR) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-09-15 | $14.00M | $13.51M | 3.57 % |
| Q4 | 2025-07-23 | $12.36M | $12.01M | 2.85 % |
| Q2 | 2024-12-11 | $13.49M | $13.05M | 3.36 % |
| Q1 | 2024-09-11 | $14.06M | $13.23M | 6.28 % |
FAQ
Quando Champions Oncology (NASDAQ:CSBR) riporterà gli utili?
Si prevede che Champions Oncology (CSBR) fornisca risultati il dicembre 10, 2025. Gli ultimi risultati sono stati pubblicati il settembre 15, 2025 per il Q1.
Quali sono stati gli ultimi utili per azione (EPS) di Champions Oncology (NASDAQ:CSBR)?
L'EPS effettivo era $0.02, che superato la stima di $-0.01.
Quali sono state le entrate di Champions Oncology (NASDAQ:CSBR)?
Le entrate effettive sono state $14M, che superato la stima di $13.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.